This content is from: Brazil

Brazil: Drugs dispute demands action

The market for pharmaceuticals in Brazil has great potential. Yet Brazil's Health Authority is in conflict with the pharmaceutical industry over IP rights, and sales are suffering. Deborah Portilho and Rana Gosain of Daniel Advogados investigate

To access our in-house intelligence please request a trial here.

Read this article – and more – for a one-week period.


Are you already an Managing IP subscriber? Login here


Instant access to all of our content. Membership Options | One Week Trial